• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Danny W. Scott, DVM, DACVD

Articles

Advertisement
Tetracyclines and niacinamide in canine dermatology (Proceedings)

The tetracyclines were initially used as bacteriostatic antibiotics. Niacinamide (the amide of niacin) is a vasodilator. These agents also have some interesting in vitro and in vivo anti-inflammatory and immunomodulatory properties.

Erythema multiforme in dogs and cats (Proceedings)

Erythema multiforme was first documented in the dog in 1983 and in the cat in 1984.

Update on malassezia dermatitis in dogs and cats (Proceedings)

Malassezia yeasts and Malassezia dermatitis have been the subject of almost innumerable publications and anecdotes since the early 1990s. The condition is diagnosed commonly in the dog and uncommonly in the cat.

Pentoxifylline in canine dermatology (Proceedings)

Pentoxifylline (PTX) has been heralded as "the drug of the decade" and "a wonder drug". There is variably believable information (anecdotal-to-scientific) suggesting the therapeutic efficacy of PTX in a staggering number of dermatoses in human and veterinary (Table 1) medicine.PTX has been reported to have a steroid-sparing effect.

Cutaneous vasculitis in dogs (Proceedings)

Cutaneous vasculitis was first documented in a dog in 1980. Vasculitides can be apparently limited to the skin or, less commonly, the skin may be one of multiple organ systems involved.

Medical management of the allergic cat (Proceedings)

Pruritus and the various aberrations of skin and hair coat that it provokes are, by far, the most common reasons for which cats are presented to veterinarians for dermatologic diagnosis.

Advertisement

Latest News

This week on dvm360.com: dvm360® continues to celebrate Pride Month, and other veterinary news

3 must-sees on creating an inclusive work culture

CityVet names new chief strategy officer

Workplace bottlenecks in the LGBTQIA+ community

View More Latest News
Advertisement